5-hydroxy-benzothiazole derivatives having...

Details 5-hydroxy-benzothiazole derivatives having... 5-hydroxy-benzothiazole derivatives having...

2005-11-28

2011-12-13

Stockton, Laura L. (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S367000

Reexamination Certificate

active

08076489

ABSTRACT:
Compounds of formula (I) in free or salt or solvate form, wherein T has the meaning as indicated in the specification, are useful for treating conditions that are prevented or alleviated by activation of the β2-adrenoreceptor. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.

REFERENCES:
patent: 4091218 (1978-05-01), Advani
patent: 4119412 (1978-10-01), Advani
patent: 5648370 (1997-07-01), Bonnert et al.
patent: 6670376 (2003-12-01), Moran et al.
patent: 2004/0167167 (2004-08-01), Mammen et al.
patent: 2004/0224982 (2004-11-01), Axt et al.
patent: 2005/0182092 (2005-08-01), Chao et al.
patent: 2006/0035933 (2006-02-01), Mammen et al.
patent: 2006/0106075 (2006-05-01), Cuenoud et al.
patent: 2007/0249586 (2007-10-01), Cuenoud et al.
patent: 2009/0264459 (2009-10-01), Collingwood et al.
patent: 2493765 (2004-02-01), None
patent: 2 565 243 (2005-11-01), None
patent: 1085899 (1994-04-01), None
patent: 52-83383 (1977-07-01), None
patent: WO 95/02585 (1995-01-01), None
patent: WO 97/10227 (1997-03-01), None
patent: WO 99/09018 (1999-02-01), None
patent: WO-99/09018 (1999-02-01), None
patent: WO 99/36095 (1999-07-01), None
patent: WO 2004/016601 (2004-02-01), None
patent: WO 2004/087142 (2004-10-01), None
patent: WO 2004/106333 (2004-12-01), None
patent: WO 2005/110990 (2005-11-01), None
Barnes et al., European Respiratory Journal (2005), 25(6), pp. 1084-1106.
Souillac, et al., Characterization of Delivery Systems, Differential Scanning Calorimetry in Encyclopedia of Controlled Drug Delivery, 1999, John Wiley & Sons, pp. 212-227.
Vippagunta et al., Advanced Drug Delivery Reviews, 48 (2001), pp. 3-26.
An English translation of WO 99/09018, 1999.
R. T. Brittain et al., “Sympathomimetic Bronchodilator Drugs”, Pharmac. Ther. B., vol. 2 (1976), pp. 423-462.
Jack, “A way of looking at agonism and antagonism: Lessons from salbutamol, salmeterol and other β-adrenoceptor agonists”, Br. J. clin. Pharmac., vol. 31 (1991), pp. 501-514.
Suzuki et al., “S1319: A Novel β2-adrenoceptor Agonist from a Marine SpongeDysideaSP.”, Bioorganic & Medicinal Chemistry Letters, vol. 9, No. 10 (1999), pp. 1361-1364.
Suzuki et al., “Tracheal relaxing effects and β2adrenoceptor selectivity of S1319, a novel sponge-derived bronchodilator agent, in isolated guinea-pig tissues”, British Journal of Pharmacology, vol. 128 (1999), pp. 716-720.
Suzuki et al., “The effects of S1319, a novel marine sponge-derived β2-adrenoceptor agonist, on IgE-mediated activation of human cultured mast cells”, Inflamm. Res., vol. 49 (2000), pp. 86-94.
Bernard Cuenoud; U.S. PTO Office Action, U.S. Appl. No. 11/823,622, Mar. 28, 2008, 13 pgs.
Bernard Cuenoud; U.S. PTO Office Action, U.S. Appl. No. 10/522,359, Jan. 9, 2007, 19 pgs.
Database WPI, Section Ch, Week 199915, Derwent Publications Ltd., London, GB, AN 1999-180948 (1999), 2 pgs.
Bernard Cuenoud; U.S. PTO Office Action, U.S. Appl. No. 11/823,622, May 14, 2010, 20 pgs.
Cuenoud; U.S. PTO Office Action, U.S. Appl. No. 11/823,622, Nov. 12, 2010, 27 pgs.
Cuenoud; U.S. PTO Advisory Action, U.S. Appl. No. 11/823,622, Feb. 18, 2011, 4 pgs.
Collingwood, U.S. PTO Restriction Requirement, U.S. Appl. No. 12/308,231, Mar. 23, 2011, 8 pgs.

Affiliated with

Also associated with

Rating

5-hydroxy-benzothiazole derivatives having... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 5-hydroxy-benzothiazole derivatives having..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-hydroxy-benzothiazole derivatives having... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4294014